Edal, Almira .
HRN: 17-96-93 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/28/2023
09/28/2023
IV
2.25g
Q8H
CAP MR; Presumptive PTB
Checking Final Appropriateness
09/28/2023
AZITHROMYCIN 500MG TABLET (TAB)
09/28/2023
10/05/2023
PO
500mg
OD
CAP MR
Checking Final Appropriateness